Lipids & metabolic liver disease

Adopting the lancet commission definition of clinical obesity in metabolic dysfunction-associated steatotic liver disease (MASLD)

Int J Obes (Lond)Published Cohort study

Authors' conclusion

Clinical obesity criteria identified more MASLD patients with F3/F4, severe steatosis, at-risk MASH and MACE compared with BMI-based obesity criteria.

Study context

Population
Asian patients with MASLD with vibration-controlled transient elastography assessment; mean age 55.8 ± 12.5 years, 49.2% male, mean BMI 28.2 ± 4.7 kg/m²254 with bioelectrical impedance analysis (BIA)
Participants
642 patients
Exposure
Clinical obesity criteria vs BMI-based obesity criteria
Outcome
Patients identified with clinical outcomes

Main finding

As reported in the abstract

Fulfilled the diagnosis of clinical obesity
46.1%
F3/F4: clinical obesity vs BMI-based criteria
20.6% vs 8.1%, p < 0.001
Severe steatosis: clinical obesity vs BMI-based criteria
83.8% vs 67.6%, p < 0.001
At-risk MASH: clinical obesity vs BMI-based criteria
3.4% vs 0%, p = 0.056
Major adverse cardiovascular events (MACE): clinical obesity vs BMI-based criteria
11.2% vs 2.7%, p = 0.006

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)P value
Clinical obesity as independent predictor of F3/F44.074 (2.195–7.563)P < 0.001
Clinical obesity as independent predictor of severe steatosis2.441 (1.638–3.637)P < 0.001

Body composition (BIA subgroup): appendicular skeletal muscle mass and visceral fat index

Lower appendicular skeletal muscle mass, clinical obesity vs BMI-based criteria
27.0% vs 41.1%, P < 0.001
Greater visceral fat index, clinical obesity vs BMI-based criteria
15 vs 9, p < 0.001

Original publication

Adopting the lancet commission definition of clinical obesity in metabolic dysfunction-associated steatotic liver disease (MASLD). Int J Obes (Lond). Published 17 July 2026. doi:10.1038/s41366-026-02173-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.